Observational Study of Patients Who Underwent Diagnostic Investigation (Prostate Biopsy) and/or Radical Prostatectomy Surgery.
Launched by IRCCS SAN RAFFAELE · Apr 29, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the quality of life and health status of men with prostate cancer who have had a prostate biopsy and/or surgery called radical prostatectomy, which is a procedure to remove the prostate gland. The goal is to better understand how these procedures affect patients over time. The study is currently looking for male participants between the ages of 65 and 74 who have been diagnosed with a suspicious prostate condition and have undergone one of these procedures.
To join the study, participants must be adults over 18 who are able to read and sign a consent form. Unfortunately, those under 18, or with certain mental or physical disabilities that might make it hard to follow the study’s requirements, cannot participate. If you take part in this study, you can expect to share information about your experiences and health after your treatment, which will help researchers learn more about prostate cancer and improve care for future patients.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Patients with a suspicious prostate disease who underwent prostate biopsy and/or radical prostatectomy;
- • Adult patients \> 18 years
- • Ability to read and sign the informed consent
- Exclusion Criteria:
- • Patients \< 18 years
- • mental or physical disability that may prevent the patient from satisfying the requirements of the protocol
- • Inability to read and sign the informed consent
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported